Inhibition of Factor Xa: A Potential Target for the Development of New Anticoagulants

Author： Alexander John H.   Singh Kanwar P.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.5, 2005-01, pp. : 279-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

New Parenteral Anticoagulants: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 129-136

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on Factor Xa Inhibition

By  

Current Medicinal Chemistry, Vol. 8, Iss. 2, 2001-02 ,pp. : 101-119

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of New Factor Xa Inhibitors Based on Amide Synthesis

By  

Current Drug Discovery Technologies, Vol. 15, Iss. 4, 2018-12 ,pp. : 335-350

Bentham Science Publishers

Access to resources Recommend Favorite

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

By Apostolakis Stavros   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1057-1064

Informa Healthcare

Access to resources Recommend Favorite